AbilityPharma raised €7 million in funding from investors including CTI Life Sciences Fund, Inveready, the EIC Fund, Fitalent and CDTI Innvierte.
02 March 2024
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom